Klinische FragestellungSifrim-Hitz-Weiss-Syndrom, Differentialdiagnose
Zusammenfassung
Kurzinformation
Gen-panel für Sifrim-Hitz-Weiss-Syndrom mit 1 "core"-Gen, 6 weiteren "core candidate"-Genen bzw. zusammen genommen 79 kuratierten Genen gemäß klinischer Verdachtsdiagnose
ID
SP9232
Anzahl Gene
79
Akkreditierte Untersuchung
Untersuchte Sequenzlänge
33,8 kb (Core-/Core-canditate-Gene)
264,6 kb (Erweitertes Panel: inkl. additional genes)
264,6 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
- EDTA-Blut (3-5 ml)
Diagnostische Hinweise
NGS +
Genpanel
Ausgewählte Gene
Name | Exon-Länge (bp) | OMIM-G | Referenz-Seq. | Erbgang |
---|---|---|---|---|
ADNP | 3309 | NM_015339.5 | AD | |
CHD4 | 5739 | NM_001273.5 | AD | |
EHMT1 | 3897 | NM_024757.5 | AD | |
KANSL1 | 3318 | NM_001193466.2 | AD | |
KAT6A | 6015 | NM_006766.5 | AD | |
MED13L | 6633 | NM_015335.5 | AD | |
SETBP1 | 4791 | NM_015559.3 | AD, SMu | |
AP2M1 | 1400 | NM_004068.4 | AD | |
ARID1A | 6858 | NM_006015.6 | AD | |
ARID1B | 6750 | NM_001374820.1 | AD | |
ARID2 | 5508 | NM_152641.4 | AD | |
ASH1L | 8895 | NM_018489.3 | AD | |
AUTS2 | 3780 | NM_015570.4 | AD | |
BCL11A | 2322 | NM_018014.4 | AD | |
BRSK2 | 2211 | NM_001256627.2 | AD | |
CAMK2A | 1493 | NM_015981.4 | AD | |
CAMK2B | 2256 | NM_001220.5 | AD | |
CAMK2G | 1620 | NM_001204492.2 | AD | |
CDH15 | 2445 | NM_004933.3 | AD | |
CERT1 | 2259 | NM_001130105.1 | AD | |
CHAMP1 | 2439 | NM_001164144.3 | AD | |
CIC | 4827 | NM_015125.5 | AD | |
CLTC | 5111 | NM_004859.4 | AD | |
CSDE1 | 2397 | NM_001007553.3 | AD | |
CSNK2B | 665 | NM_001320.7 | AD | |
CTCF | 1200 | NM_006565.4 | AD | |
CTNNB1 | 2346 | NM_001904.4 | AD | |
CUX1 | 4518 | NM_001202543.2 | AD | |
DEAF1 | 1698 | NM_021008.4 | AD, AR | |
DLG4 | 2166 | NM_001128827.4 | AD | |
DPF2 | 1175 | NM_006268.5 | AD | |
DPP6 | 2406 | NM_001039350.3 | AD | |
DYNC1H1 | 13941 | NM_001376.5 | AD | |
DYRK1A | 2292 | NM_001396.5 | AD | |
EEF1A2 | 1392 | NM_001958.5 | AD | |
EPB41L1 | 2643 | NM_001258329.1 | AD | |
FOXP1 | 2034 | NM_032682.6 | AD | |
GATAD2B | 1782 | NM_020699.4 | AD | |
GNB1 | 1032 | NM_002074.5 | AD | |
GRIA4 | 3017 | NM_000829.4 | AD | |
GRIN2B | 4455 | NM_000834.5 | AD | |
HIVEP2 | 7341 | NM_006734.4 | AD | |
KCNQ5 | 2772 | NM_001160130.2 | AD | |
KDM4B | 4291 | NM_015015.3 | AD | |
KMT5B | 1182 | NM_017635.5 | AD | |
MBD5 | 4485 | NM_018328.5 | AD | |
MED13 | 6525 | NM_005121.3 | AD | |
MYT1L | 3555 | NM_015025.4 | AD | |
NAA15 | 2601 | NM_057175.5 | AD | |
NBEA | 2220 | NM_015678.5 | AD | |
NUS1 | 887 | NM_138459.5 | AD, AR | |
PACS1 | 2892 | NM_018026.4 | AD | |
POGZ | 4233 | NM_015100.4 | AD | |
PPP2R1A | 1770 | NM_014225.6 | AD | |
PPP2R5D | 1356 | NM_006245.4 | AD | |
PURA | 969 | NM_005859.5 | AD | |
RAC1 | 579 | NM_006908.5 | AD | |
RORA | 1647 | NM_002943.4 | AD | |
SCN8A | 5943 | NM_014191.4 | AD | |
SET | 1124 | NM_001122821.2 | AD | |
SETD5 | 4329 | NM_001080517.3 | AD | |
SMARCA4 | 5040 | NM_001128849.3 | AD | |
SMARCB1 | 1158 | NM_003073.5 | AD | |
SMARCC2 | 3459 | NM_003075.5 | AD | |
SMARCE1 | 1236 | NM_003079.5 | AD | |
SOX11 | 1326 | NM_003108.4 | AD | |
STAG1 | 3777 | NM_005862.3 | AD | |
SYNGAP1 | 4032 | NM_006772.3 | AD | |
SYT1 | 1277 | NM_005639.3 | AD | |
TAOK1 | 3025 | NM_020791.4 | AD | |
TBL1XR1 | 1545 | NM_024665.7 | AD | |
TBR1 | 2049 | NM_006593.4 | AD | |
TLK2 | 2372 | NM_006852.6 | AD | |
TRIM8 | 1796 | NM_030912.3 | AD | |
TRIO | 9294 | NM_007118.4 | AD | |
TRIP12 | 5979 | NM_004238.3 | AD | |
ZBTB18 | 1596 | NM_205768.3 | AD | |
ZMYND11 | 1647 | NM_006624.7 | AD | |
ZNF292 | 8172 | NM_015021.3 | AD |
Infos zur Erkrankung
Synonyme
- Alias: CHD4 neurodevelopmental disorder
- Allelic: Charcot-Marie-Tooth disease, axonal, type 20 (DYNC1H1)
- Allelic: Exudative vitreoretinopathy 7 (CTNNB1)
- Allelic: Meningioma, familial, susceptibility to (SMARCE1)
- Allelic: Mental retardation, AR 63 (CAMK2A)
- Allelic: Myoclonus, familial, 2 (SCN8A)
- Allelic: Rhabdoid tumor predisposition syndrome 2 (SMARCA4)
- Allelic: Schwannomatosis-1, susceptibility to (SMARCB1)
- Allelic: Seizures, benign familial infantile, 5 (SCN8A)
- Allelic: Spinal muscular atrophy, lower extremity-predominant 1, AD (DYNC1H1)
- Arboleda-Tham syndrome (KAT6A)
- Baker-Gordon syndrome (SYT1)
- Coffin-Siris syndrome 1 (ARID1B)
- Coffin-Siris syndrome 2 (ARID1A)
- Coffin-Siris syndrome 3 (SMARCB1)
- Coffin-Siris syndrome 4 (SMARCA4)
- Coffin-Siris syndrome 5 (SMARCE1)
- Coffin-Siris syndrome 6 (ARID2)
- Coffin-Siris syndrome 7 (DPF2)
- Coffin-Siris syndrome 8 (SMARCC2)
- Coffin-Siris syndrome 9 (SOX11)
- Cognitive impairment with/-out cerebellar ataxia (SCN8A)
- Congenital disorder of glycosylation, type 1aa (NUS1)
- Developmental + epileptic encephalopathy 13 (SCN8A)
- Developmental + epileptic encephalopathy 27 (GRIN2B)
- Developmental + epileptic encephalopathy 33 (EEF1A2)
- Developmental delay with/-out intellectual impairment or behavioral abnormalities (TAOK1)
- Dias-Logan syndrome (BCL11A)
- Focal segmental glomerulosclerosis + neurodevelopmental syndrome (TRIM8)
- GAND syndrome (GATAD2B)
- Global developmental delay with/-out impaired intellectual development (CUX1)
- Global developmental delay, ID, autism [panelapp] (CSDE1)
- Global developmental delay, ID, autism, behavioral abnormality [panelapp] (BRSK2)
- Helsmoortel-van der Aa syndrome (ADNP)
- Impaired intellectual development, distinctive facial features with/-out cardiac defects (MED13L)
- Intellectual developmental disorder 60 with seizures (AP2M1)
- Intellectual developmental disorder 61 (MED13)
- Intellectual developmental disorder 62 (DLG4)
- Intellectual developmental disorder with autism + speech delay (TBR1)
- Intellectual developmental disorder with/-out epilepsy or cerebellar ataxia (RORA)
- Intellectual developmental disorder, AD 11 (EPB41L1)
- Intellectual developmental disorder, AD 26 (AUTS2)
- Intellectual developmental disorder, AD 42 (GNB1)
- Intellectual developmental disorder, AD 44, with microcephaly (TRIO)
- Intellectual developmental disorder, AD 50, with behavioral abnormalities (NAA15)
- Intellectual developmental disorder, AD 6, with/-out seizures (GRIN2B)
- Intellectual developmental disorder, AD 63, with macrocephaly (TRIO)
- Intellectual developmental disorder, AD 64 (ZNF292)
- Intellectual developmental disorder, AD 65 (KDM4B)
- Kleefstra syndrome 1 (EHMT1)
- Koolen-De Vries syndrome (KANSL1)
- Mental retardation with language impairment with/-out autistic features (FOXP1)
- Mental retardation, AD 1 (MBD5)
- Mental retardation, AD 10 (CACNG2)
- Mental retardation, AD 13 (DYNC1H1)
- Mental retardation, AD 21 (CTCF)
- Mental retardation, AD 22 (ZBTB18)
- Mental retardation, AD 23 (SETD5)
- Mental retardation, AD 29 (SETBP1)
- Mental retardation, AD 3 (CDH15)
- Mental retardation, AD 30 (ZMYND11)
- Mental retardation, AD 33 (DPP6)
- Mental retardation, AD 34 (CERT1 syn. COL4A3BP)
- Mental retardation, AD 35 (PPP2R5D)
- Mental retardation, AD 36 (PPP2R1A)
- Mental retardation, AD 38 (EEF1A2)
- Mental retardation, AD 39 (MYT1L)
- Mental retardation, AD 40 (CHAMP1)
- Mental retardation, AD 41 (TBL1XR1)
- Mental retardation, AD 43 (HIVEP2)
- Mental retardation, AD 45 (CIC)
- Mental retardation, AD 46 (KCNQ5)
- Mental retardation, AD 47 (STAG1)
- Mental retardation, AD 48 (RAC1)
- Mental retardation, AD 49 (TRIP12)
- Mental retardation, AD 5 (SYNGAP1)
- Mental retardation, AD 51 (KMT5B)
- Mental retardation, AD 52 (ASH1L)
- Mental retardation, AD 53 (CAMK2A)
- Mental retardation, AD 54 (CAMK2B)
- Mental retardation, AD 55, with seizures (NUS1)
- Mental retardation, AD 56 (CLTC)
- Mental retardation, AD 57 (TLK2)
- Mental retardation, AD 58 (SET)
- Mental retardation, AD 59 (CAMK2G)
- Mental retardation, AD 7 (DYRK1A)
- Neurodevelopmental disorder with hypotonia, impaired expressive language, +/- seizures (DEAF1)
- Neurodevelopmental disorder with spastic diplegia + visual defects (CTNNB1)
- Neurodevelopmental disorder with/-out early-onset generalized epilepsy (NBEA)
- Neurodevelopmental disorder with/-out seizures + gait abnormalities (GRIA4)
- Neurodevelopmental disorder, neonatal respiratory insufficiency, hypotonia, feeding diffic. (PURA)
- Pierpont syndrome (TBL1XR1)
- Poirier-Bienvenu neurodevelopmental syndrome (CSNK2B)
- Rhabdoid tumor predisposition syndrome 1 (SMARCB1)
- Schinzel-Giedion midface retraction syndrome (SETBP1)
- Schuurs-Hoeijmakers syndrome (PACS1)
- Vulto-van Silfout-de Vries syndrome (DEAF1)
- White-Sutton syndrome (POGZ)
Erbgänge, Vererbungsmuster etc.
- AD
- AR
- SMu
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
Bioinformatik und klinische Interpretation
Kein Text hinterlegt